Search Results 1331-1340 of 11230 for Antifungal Resistance

1. Azacitidine And Sonidegib In Treating Patients With Myeloid Malignancies - Mayo Clinic

   ... antifungal/antiviral medications are allowed unless listed as contraindicated; Any of the following prior therapies: Cytotoxic Chemotherapy ≤ 14 days prior ...

2. A Study Of ABBV-085, An Antibody Drug Conjugate, For Patients With Advanced Solid Cancer Tumors - Mayo Clinic

   The purpose of this study is to evaluate the safety and drug/body interactions of ABBV-085, and to determine the recommended future study dose (alone or in ...

3. Study Of Zoldonrasib + Chemo Of Investigator's Choice Vs Placebo + Chemo Of Investigator's Choice As First-line Treatment In Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) - Mayo Clinic

   The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared to placebo ...

4. Hematology - Clinical trials

   ... Resistant to Current Standard of Care Treatments. Rochester, Minn. This phase ... resistant chronic lymphocytic leukemia. Patients will be randomized 1 ...

5. Study Of DS-1062a In Advanced Or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) - Mayo Clinic

   Uncontrolled infection requiring IV antibiotics, antivirals, or antifungals. Note: Subjects with localized fungal infections of skin or nails are eligible.

6. Study For The Treatment Of Cytomegalovirus (CMV) Infection In Hematopoietic Stem Cell Transplant Recipients - Mayo Clinic

   Have a CMV infection that is known to be genotypically resistant to ganciclovir, valganciclovir, foscarnet, or cidofovir based on documented evidence. Be ...

7. Autoimmune Disease - Mayo Clinic Healthcare

   Using advanced diagnostic testing and a multidisciplinary approach, our consultants aim to identify the underlying cause of your symptoms, define the specific ...

8. A Study To Evaluate AFPᶜ³³²T In Advanced HCC - Mayo Clinic

   The purpose of this study is to test the safety of genetically changed T cells that target alpha-fetoprotein (AFP) and find out what effects, if any, they have ...

9. A Phase 1/2a Dose-Finding Study Of PT-112 In Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...

10. Study Investigating The Activity Of Vidofludimus Calcium As A Treatment For Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...